About Andrew Alegria
Form D filings for Objective Biotechnology in 2024 list Andrew Alegria as executive officer and director.
Andrew Alegria first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Alegria in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Alegria works with at each company, as listed on that company's latest Form D.
Objective Biotechnology, Inc. · Form D, Nov 26, 2024
JG
James Grabau
CEO
DS
Daniel Surinach
Executive officer and director
AJ
Amey Joshi
Executive officer and director
SK
Suhasa Kodandaramaiah
Executive officer and director
DG
Daryl Gohl
Executive officer and director